Free Trial

MiMedx Group (MDXG) Competitors

$7.15
+0.03 (+0.42%)
(As of 05/31/2024 ET)

MDXG vs. XENT, ATEC, CRY, OFIX, SIBN, HAE, PRCT, AXNX, TNDM, and NARI

Should you be buying MiMedx Group stock or one of its competitors? The main competitors of MiMedx Group include Intersect ENT (XENT), Alphatec (ATEC), CryoLife (CRY), Orthofix Medical (OFIX), SI-BONE (SIBN), Haemonetics (HAE), PROCEPT BioRobotics (PRCT), Axonics (AXNX), Tandem Diabetes Care (TNDM), and Inari Medical (NARI). These companies are all part of the "medical" sector.

MiMedx Group vs.

MiMedx Group (NASDAQ:MDXG) and Intersect ENT (NASDAQ:XENT) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, community ranking, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership.

Intersect ENT received 372 more outperform votes than MiMedx Group when rated by MarketBeat users. However, 77.27% of users gave MiMedx Group an outperform vote while only 60.24% of users gave Intersect ENT an outperform vote.

CompanyUnderperformOutperform
MiMedx GroupOutperform Votes
34
77.27%
Underperform Votes
10
22.73%
Intersect ENTOutperform Votes
406
60.24%
Underperform Votes
268
39.76%

MiMedx Group currently has a consensus target price of $12.25, indicating a potential upside of 71.33%. Given MiMedx Group's higher probable upside, research analysts plainly believe MiMedx Group is more favorable than Intersect ENT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MiMedx Group
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
Intersect ENT
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

MiMedx Group has a net margin of 18.63% compared to Intersect ENT's net margin of -161.94%. MiMedx Group's return on equity of 39.42% beat Intersect ENT's return on equity.

Company Net Margins Return on Equity Return on Assets
MiMedx Group18.63% 39.42% 13.70%
Intersect ENT -161.94%-709.52%-48.18%

79.2% of MiMedx Group shares are held by institutional investors. Comparatively, 92.5% of Intersect ENT shares are held by institutional investors. 1.3% of MiMedx Group shares are held by insiders. Comparatively, 2.1% of Intersect ENT shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, MiMedx Group had 3 more articles in the media than Intersect ENT. MarketBeat recorded 3 mentions for MiMedx Group and 0 mentions for Intersect ENT. MiMedx Group's average media sentiment score of 1.08 beat Intersect ENT's score of 0.00 indicating that MiMedx Group is being referred to more favorably in the media.

Company Overall Sentiment
MiMedx Group Positive
Intersect ENT Neutral

MiMedx Group has higher revenue and earnings than Intersect ENT. Intersect ENT is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MiMedx Group$321.48M3.28$58.23M$0.4416.25
Intersect ENT$106.75M8.95-$159.63M-$4.79-5.90

MiMedx Group has a beta of 1.44, meaning that its share price is 44% more volatile than the S&P 500. Comparatively, Intersect ENT has a beta of 1.45, meaning that its share price is 45% more volatile than the S&P 500.

Summary

MiMedx Group beats Intersect ENT on 12 of the 17 factors compared between the two stocks.

Get MiMedx Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDXG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDXG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MDXG vs. The Competition

MetricMiMedx GroupSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1.06B$3.86B$5.13B$7.96B
Dividend YieldN/A1.82%2.75%4.01%
P/E Ratio16.2516.07167.1718.57
Price / Sales3.2871.072,418.7891.65
Price / Cash37.8648.1735.3031.51
Price / Book6.755.075.534.59
Net Income$58.23M$4.50M$106.01M$213.90M
7 Day Performance-7.74%1.27%1.14%0.87%
1 Month Performance-2.19%0.10%1.43%3.60%
1 Year Performance23.49%-17.03%4.07%7.91%

MiMedx Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
XENT
Intersect ENT
0 of 5 stars
$28.24
flat
N/A+0.0%$954.91M$106.75M-5.90433Analyst Forecast
ATEC
Alphatec
4.535 of 5 stars
$10.12
+0.2%
$22.89
+126.2%
-36.6%$1.42B$482.26M-6.79839Short Interest ↓
Positive News
CRY
CryoLife
0 of 5 stars
N/AN/AN/A$703.22M$253.23M596.201,200
OFIX
Orthofix Medical
1.0601 of 5 stars
$14.89
+0.1%
$18.00
+20.9%
-26.9%$558.82M$746.64M-4.411,634
SIBN
SI-BONE
3.6856 of 5 stars
$13.55
+1.0%
$27.29
+101.4%
-44.3%$558.40M$138.89M-12.43344
HAE
Haemonetics
4.705 of 5 stars
$88.34
-0.3%
$108.67
+23.0%
-2.8%$4.49B$1.31B38.583,657Insider Selling
PRCT
PROCEPT BioRobotics
1.3418 of 5 stars
$66.90
+0.3%
$61.20
-8.5%
+104.4%$3.44B$136.19M-31.56626Analyst Revision
Positive News
AXNX
Axonics
2.6276 of 5 stars
$67.22
-0.2%
$70.30
+4.6%
+36.1%$3.43B$366.38M-210.06797Short Interest ↑
Positive News
TNDM
Tandem Diabetes Care
2.8703 of 5 stars
$51.73
+4.1%
$49.73
-3.9%
+108.6%$3.34B$770.01M-23.842,400Analyst Forecast
Analyst Revision
News Coverage
NARI
Inari Medical
3.2398 of 5 stars
$49.95
+5.3%
$65.71
+31.6%
-19.8%$2.90B$493.63M-121.831,300Insider Selling
News Coverage

Related Companies and Tools

This page (NASDAQ:MDXG) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners